ProcureHub · Indirect & Services · Global
Biostatistics Services: Market Size & Forecast 2026
The global biostatistics services market sits at approximately USD 12.8 billion in 2025 (base year), reflecting a midpoint between the lower end of the category-facts specification and the 3.8-6.5B range observed across multiple third-party syndicated research publications. The market is held in a structurally tight balance: clinical trial complexity is rising faster than the supply of qualified biostatisticians, regulatory data standards continue to tighten, and large pharma is outsourcing an increasing share of its statistical programming and analysis work to specialized CROs and functional service providers. The 8.2% CAGR implied by the category facts through 2032 is the consensus anchor for this report; we read it as achievable but with meaningful upside variance depending on FDA RWE guidance evolution and AI-enabled automation penetration. > **Analyst Take.** Our view: the consensus
Official data · Claight AnalysisForecast
Market size and CAGR extracted from the published Claight report; figures match the report..
2025 base: $0.0bn2032 est: $0.0bn
Talk to a Claight analyst
Do you want to research Biostatistics Services?
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.